FDAFDA · Food and drugs·Recall number D-0388-2026
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Published March 11, 2026 · Recall initiated: October 20, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- ANTHONY TRINH, 123Herbals LLC
- Distributor
- USA nationwide
- Lot
- All lots within expiry
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.